文献速递疼痛医学

截短型μ阿片受体6次跨膜变异体对阿片镇痛至关重要

Truncated μ-Opioid Receptors With 6 Transmembrane Domains Are Essential for Opioid Analgesia.
PubMed 文献 · Anesth Analg · 2018-01-01

本研究在小鼠中通过慢病毒表达5种6TM变异体,发现所有变异体均能在E1/E11双敲除小鼠中恢复IBNtxA镇痛而不恢复吗啡镇痛,且恢复的IBNtxA效力与野生型无差别,镇痛维持可达33周并可被levallorphan拮抗。

要点

  • 6TM变异体是IBNtxA镇痛所必需,而非吗啡镇痛所必需。
  • 慢病毒恢复6TM变异体表达可恢复IBNtxA镇痛,效力与野生型无差别。
  • 6TM变异体为无传统阿片副作用的镇痛药提供潜在靶点。

核心结论

  • 小鼠6TM变异体在IBNtxA镇痛中具有药理学相关性,由外显子2和3编码的跨膜结构域构成的功能核心足以介导活性。
  • 6TM变异体为针对广谱疼痛模型且无传统阿片多数副作用的独特镇痛药提供了潜在治疗靶点。

研究设计与样本

  • 研究使用表达6TM变异体的慢病毒在HEK293T细胞中包装、超速离心浓缩后鞘内注射3次。
  • 在E1/E11双敲除小鼠中评估慢病毒表达各6TM变异体对IBNtxA镇痛的影响,采用辐射热甩尾实验测定镇痛。

主要发现

  • 所有6TM变异体均在E1/E11敲除小鼠中恢复IBNtxA镇痛,而吗啡仍无活性。
  • 慢病毒6TM变异体mRNA表达经PCR或定量PCR确认。
  • 在恢复小鼠中通过累积剂量-反应研究确定的IBNtxA半数有效剂量值与野生型动物无法区分。
  • IBNtxA镇痛在恢复小鼠中维持长达33周,并可被阿片拮抗剂levallorphan轻易拮抗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Most clinical opioids act through μ-opioid receptors. They effectively relieve pain but are limited by side effects, such as constipation, respiratory depression, dependence, and addiction. Many efforts have been made toward developing potent analgesics that lack side effects. Three-iodobenzoyl-6β-naltrexamide (IBNtxA) is a novel class of opioid active against thermal, inflammatory, and neuropathic pain, without respiratory depression, physical dependence, and reward behavior. The μ-opioid receptor (OPRM1) gene undergoes extensive alternative precursor messenger ribonucleic acid splicing, generating multiple splice variants that are conserved from rodents to humans. One type of variant is the exon 11 (E11)-associated truncated variant containing 6 transmembrane domains (6TM variant). There are 5 6TM variants in the mouse OPRM1 gene, including mMOR-1G, mMOR-1M, mMOR-1N, mMOR-1K, and mMOR-1L. Gene-targeting mouse models selectively removing 6TM variants in E11 knockout (KO) mice eliminated IBNtxA analgesia without affecting morphine analgesia. Conversely, morphine analgesia is lost in an exon 1 (E1) KO mouse that lacks all 7 transmembrane (7TM) variants but retains 6TM variant expression, while IBNtxA analgesia remains intact. Elimination of both E1 and E11 in an E1/E11 double KO mice abolishes both morphine and IBNtxA analgesia. Reconstituting expression of the 6TM variant mMOR-1G in E1/E11 KO mice through lentiviral expression rescued IBNtxA but not morphine analgesia. The aim of this study was to investigate the effect of lentiviral expression of the other 6TM variants in E1/E11 KO mice on IBNtxA analgesia. METHODS: Lentiviruses expressing 6TM variants were packaged in HEK293T cells, concentrated by ultracentrifugation, and intrathecally administered 3 times. Opioid analgesia was determined using a radiant-heat tail-flick assay. Expression of lentiviral 6TM variant messenger ribonucleic acids was examined by polymerase chain reaction (PCR) or quantitative PCR. RESULTS: All the 6TM variants restored IBNtxA analgesia in the E1/E11 KO mouse, while morphine remained inactive. Expression of lentiviral 6TM variants was confirmed by PCR or quantitative PCR. IBNtxA median effective dose values determined from cumulative dose-response studies in the rescued mice were indistinguishable from wild-type animals. IBNtxA analgesia was maintained for up to 33 weeks in the rescue mice and was readily antagonized by the opioid antagonist levallorphan. CONCLUSIONS: Our study demonstrated the pharmacological relevance of mouse 6TM variants in IBNtxA analgesia and established that a common functional core of the receptors corresponding to the transmembrane domains encoded by exons 2 and 3 is sufficient for activity. Thus, 6TM variants offer potential therapeutic targets for a distinct class of analgesics that are effective against broad-spectrum pain models without many side effects associated with traditional opioids.

来源:Anesth Analg,查看原文。版权归原作者所有。

引用

  1. Lu Z, Xu J, Xu M, et al. Truncated μ-Opioid Receptors With 6 Transmembrane Domains Are Essential for Opioid Analgesia. Anesth Analg. 2018. PMID: 28991118. doi:10.1213/ANE.0000000000002538

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。